Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05336396 · ClinicalTrials.gov registry record · NA
Impact of Brief Motivational Interviewing on Periodontal Clinical Outcomes: a 3-year Post-trial Follow-up
A NA study of Periodontal Diseases and Plaque Score, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT05336396: Completed NA study of Periodontal Diseases and Plaque Score, sponsored by University of Minnesota.
NCT05336396 is a NA study of Periodontal Diseases and Plaque Score that has completed, run by University of Minnesota. The registered enrollment target is 58 participants, below the 158-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05336396, a NA study of Periodontal Diseases and Plaque Score, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is a 3-year follow-up clinical trial to evaluate longitudinal indicators of periodontal disease (plaque score, bleeding on probing (BOP), and gingival index (GI)) in 58 participants who completed NCT03571958. These participants were randomized to a brief motivational (BMI) test group or a traditional oral hygiene instruction (OHI) group for a 1-year clinical trial from 2018-2020. In addition, analysis of retrospective data to determine health topics that emerge from the behavior change strategy of BMI compared to traditional OHI by transcription of audio recordings from 2018-2020.
Primary Outcome
Excellent hygiene: 0-20%, Good hygiene: 21-40%, Fair hygiene: 41-60%, Poor hygiene: 61-100%
Conditions Studied
Interventions
- OTHER BMI
Study Locations (1)
Minnesota
- School of Dentistry - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2023-03-25 |
| Phase | NA |
What the finished NCT05336396 record still lists
NCT05336396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 158-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (63% lower).
The record links to 4 conditions, with Periodontal Diseases appearing as the primary indexed condition, and to 1 intervention - of which BMI is the first listed.
NCT05336396 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05336396 about?
NCT05336396 is a clinical study titled "Impact of Brief Motivational Interviewing on Periodontal Clinical Outcomes: a 3-year Post-trial Follow-up". The objective is a 3-year follow-up clinical trial to evaluate longitudinal indicators of periodontal disease (plaque score, bleeding on probing (BOP), and gingival index (GI)) in 58 participants who completed NCT03571958. These participants were randomized to a brief motivational (BMI) test group o...
What is the current status of trial NCT05336396?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2019-05-20. Estimated completion is 2023-03-25.
What conditions does trial NCT05336396 study?
This clinical trial studies the following conditions: Periodontal Diseases, Plaque Score, Bleeding on Probing, Gingival Index.
What interventions are being tested in trial NCT05336396?
The interventions under investigation include: BMI (OTHER).
Who is sponsoring clinical trial NCT05336396?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05336396 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periodontal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05336396's enrollment target sits among peer trials
58 10th of 15 higher than 6 of 15 other Periodontal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Periodontal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
RECRUITING · NA
-
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
RECRUITING · NA
-
Microsurgery and Periodontal Healing
RECRUITING · NA
-
Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI